Beyond CPhI: NTC is running talks and negotiations with the aim to reinforce and expand its reach internationally

  • Nov 27, 2018

One month passed since last CPhI in Madrid. There, NTC team met more than 200 potential customers and suppliers coming from 50 countries all over the world.

ESCRS: NTC presented the protocol of Leader7, one of the largest clinical trials in ophthalmology at European level of the last decade

  • Sep 24, 2018

NTC, the Italian pharmaceutical company, presented at the ESCRS (European Society of Cataract & Refractive Surgeons) Congress of Vienna the protocol of Leader7, one of the largest clinical trials in ophthalmology at European level of the last decade.

Rationalization of prescriptive behaviors in ophthalmology for the containment of antibiotic resistance

  • Sep 03, 2018

On September 22 nd, during the ESCRS Congress in Wien, NTC organizes a Satellite Symposium: "Rationalization of prescriptive behaviours in ophthalmology for the containment of antibiotic resistance".

Mundipharma extends partnership with NTC for licensing and distribution rights for ophthalmology portfolio into Latin America

  • Jul 25, 2018

Mexico City, 25 July 2018: Mundipharma has expanded its ophthalmology portfolio in Latin America by agreeing a new commercial partnership with NTC – an Italian pharmaceutical company with deep experience in research and development – for exclusive rights to license and distribute a range of ophthalmic medicines across the region...

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. READ MORE